Section 33P of the Drugs and Cosmetics Act, 1940 empowers the Central Government to give binding directions to State Governments for carrying into execution any provision of the Act or rules made thereunder. It is the only provision in the Act capable of converting prosecution norms from non-binding DCC recommendations into legally mandatory instructions for State Drug Controllers and Drug Inspectors. Yet since its insertion into the Act, Section 33P has been exercised only twice — both in 2012, on the comparatively minor issue of generic drug names on licences. It has never been used to prescribe prosecution thresholds, mandatory enforcement standards, or uniform quality enforcement norms. This article argues that systematic underuse of Section 33P is the single most important structural cause of India’s fragmented and ineffective drug enforcement regime, and calls for its immediate activation to fill the enforcement uniformity gap that DCC guidelines have failed — for structural reasons — to fill.

INTRODUCTION

India’s drug enforcement landscape is startlingly fragmented. States with identical legal frameworks — the same Drugs and Cosmetics Act, the same Rules, the same DCC guidelines — produce radically different enforcement outcomes. Some states prosecute aggressively for NSQ drug findings; others resolve the same findings with a one-day licence suspension. The same manufacturer, with the same drug quality failure, faces prison in one state and a nominal fine in another.

This fragmentation is not the product of legitimate jurisdictional diversity — it is the product of a regulatory gap. The DCC’s prosecution guidelines, which represent the only national-level attempt at enforcement uniformity, are advisory recommendations that carry no mandatory force and cannot bind State Drug Controllers as a matter of law.

Section 33P of the Act provides the solution. But it has never been used for this purpose. This article argues that it must be.

THE TEXT AND SCOPE OF SECTION 33P

Section 33P reads: ‘The Central Government may give such directions to any State Government as may appear to the Central Government to be necessary for carrying into execution in the State any of the provisions of this Act or of any rule or order made thereunder.’

Three features of Section 33P deserve attention.

First, the directions are to be given to State Governments — not to individual Drug Inspectors. This means Section 33P directions bind the State Government, which in turn is obligated under the Act to ensure compliance by its Drug Controllers and Inspectors.

Second, the directions must relate to ‘carrying into execution’ a provision of the Act, rule, or order. This means Section 33P cannot be used to impose obligations not contemplated by the Act — it is a tool for uniform execution of existing obligations, not for creating new ones.

Third, the provision uses the word ‘may’ — it is a power, not a duty. The Central Government is not obligated to issue Section 33P directions. But once issued, they are mandatory for State Governments.

THE ONLY TWO DOCUMENTED EXERCISES: 2012

To date, Section 33P appears to have been formally exercised only twice, both in October 2012:

First Direction (October 1, 2012): The Central Government directed all State/UT Governments to instruct drug licensing authorities to grant and renew drug manufacturing licences only in proper and generic names, as required under Rule 96(1)(i) of the D&C Rules, 1945. This addressed a specific, narrow problem: some states were issuing licences using brand names rather than generic names.

Second Direction (October 1, 2012): The Central Government directed all State/UT Governments to ensure that drug licensing authorities abide by the prescribed provisions under the Act regarding manufacturing licences.

Both directions dealt with the comparatively minor issue of licence nomenclature. Neither addressed prosecution standards, NSQ enforcement thresholds, or mandatory quality enforcement procedures. The immense potential of Section 33P to harmonise drug enforcement across India has never been realised.

THE ENFORCEMENT UNIFORMITY PROBLEM

The consequences of not using Section 33P for enforcement uniformity are documented and severe:

RTI-based research revealed that Gujarat imposed a one-day licence suspension on manufacturers of grossly substandard drugs, while Uttarakhand imposed twenty days. Neither state prosecuted. Other states imposed suspensions of between three and ten days. No state consistently prosecuted Category B NSQ findings — the standard that the Act’s strict liability provisions require.

This fragmentation creates a ‘race to the bottom’ dynamic: manufacturers who are aware that enforcement in certain states is perfunctory deliberately locate manufacturing facilities in those states to minimise regulatory risk. The market outcome is systematic underinvestment in quality — rational behaviour given the regulatory environment, but catastrophic for public health.

A Section 33P direction specifying minimum prosecution standards for NSQ drug findings — binding on all State Drug Controllers — would immediately and uniformly raise the enforcement baseline across all 36 states and UTs.

A DRAFT FRAMEWORK FOR SECTION 33P PROSECUTION DIRECTIONS

A model Section 33P direction on prosecution uniformity might include:

1. Mandatory prosecution within 90 days of receipt of a Government Analyst report confirming an NSQ finding, unless a specific exemption is granted by the State Drug Controller in writing with reasons recorded.
2. Prohibition on resolution of NSQ findings through administrative action alone (licence suspension, warning) where the finding relates to potency, sterility, or identity failures — Category A and serious Category B failures.
3. Mandatory reporting to the DCGI of all NSQ findings and the prosecution/non-prosecution decision within 30 days of the Analyst’s report.
4. Uniform application of pharmacopoeial quality standards (not the DCC’s 70% label claim threshold) as the sole benchmark for determining whether an NSQ finding warrants prosecution.

Such a direction would not create new law — it would direct State Governments to execute existing law. It would be entirely within the scope of Section 33P.

COMPARATIVE: SECTION 119 IT ACT AND SECTION 37B CENTRAL EXCISE ACT

The experience of CBDT and the Central Board of Excise and Customs (CBEC/CBIC) with analogous binding direction provisions is instructive.

Section 119 of the IT Act and Section 37B of the Central Excise Act both empower the respective Boards to issue binding instructions to subordinate officers for uniform administration of the Act. These provisions are used extensively — CBDT alone has issued hundreds of circulars and instructions that bind all Income Tax Officers nationally, ensuring enforcement uniformity across all Assessment Units.

The D&C Act’s Section 33P is structurally equivalent to these provisions — but operates at the Central-to-State level rather than within a single national cadre. There is no legal or structural obstacle to its use for prosecution uniformity purposes. The obstacle is purely one of political will.

VII. CONCLUSION: A POLICY RECOMMENDATION

Section 33P of the Drugs and Cosmetics Act is the most powerful unused tool in India’s drug enforcement arsenal. Its activation for prosecution uniformity purposes requires no legislative amendment, no Parliamentary procedure, and no inter-ministerial negotiation beyond the Ministry of Health. A cabinet decision and a Gazette notification suffice.

The Ministry of Health and Family Welfare should, as an urgent priority, exercise the Section 33P power to issue binding directions to all State Governments specifying minimum prosecution standards for NSQ drug findings. This single step would do more for drug enforcement uniformity in India than any amount of DCC advisory recommendations, CDSCO guidance documents, or inter-state best-practice sharing exercises.

REFERENCES

[1] The Drugs and Cosmetics Act, 1940, Section 33P — India Code.  https://www.indiacode.nic.in/bitstream/123456789/15278/1/drug_cosmeticsa1940-23.pdf

[2] Section 33P — LawGist: The Drugs and Cosmetics Act.  https://lawgist.in/drugs-and-cosmetics-act/33P

[3] PIB: Generic Names of Drugs on the Packing — Section 33P Direction (October 2012).  https://www.pib.gov.in/newsite/PrintRelease.aspx?relid=94925

[4] PIB: Manufacturing and Marketing of Banned/Unapproved Drugs — Section 33P Direction (October 2012).  https://pib.gov.in/newsite/PrintRelease.aspx?relid=101213

[5] Dinesh Thakur & Prashant Reddy T., ‘A Report on Fixing India’s Broken Drug Regulatory Framework’ (June 2016).  https://spicyip.com/wp-content/uploads/2016/06/Report_India-Drug-Regulatory-Framework_June-2016.pdf

[6] DCC Guidelines for Taking Action on Samples of Drugs Declared Spurious or NSQ — CDSCO (2008).  https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/Consumer_Section_PDFs/DCC_Guidelines_Spurious_Drugs.pdf

[7] Income Tax Act, 1961, Section 119 — Income Tax Department.  https://www.incometaxindia.gov.in

[8] PharmaBAz DCC asks expert committee to relook at guidelines for uniform prosecution — PharmaBiz (March 2025).  https://pharmabiz.com/NewsDetails.aspx?aid=175579&sid=1

[9] ICLG India — Drug and Medical Device Litigation 2026.  https://iclg.com/practice-areas/drug-and-medical-device-litigation/india

The post Section 33P of the Drugs and Cosmetics Act: India’s Unused Instrument for Uniform Drug Law Enforcement appeared first on Bhatt & Joshi Associates.

1. INTRODUCTION: THE DUAL-ROUTE ASSESSMENT MECHANISM

The Unique Feature of Transfer Pricing Assessment

Unlike ordinary income tax assessments, transfer pricing assessments have a mandatory intermediate step: the Dispute Resolution Panel (DRP).

The pathway:

text

Transfer Pricing Case Filed

        ↓

TPO (Transfer Pricing Officer) Makes Adjustment

        ↓

AO (Assessing Officer) Issues DRAFT ORDER

        ↓

ASSESSEE HAS 30 DAYS TO FILE DRP OBJECTIONS

        ↓

IF FILED: DRP Hears & Issues Binding Directions → AO Issues Final Order → Appeal to ITAT

IF NOT FILED: AO Issues Final Order → Appeal to CIT(A) [Not ITAT]

        ↓

ITAT Decides (if DRP route taken)

        ↓

High Court Appeal (on substantial question of law)

This dual-route mechanism creates a critical decision point: Whether to invoke DRP or let it lapse.

Why This Matters: Strategic Implications

If you invoke DRP:

• Binding directions issued (cannot be easily challenged)
• Final order is appealable only to ITAT (not CIT(A))
• Must accept DRP’s reasoning (even if you disagree)

If you do NOT invoke DRP:

• Standard CIT(A) appeal available (more traditional)
• But you’ve waived the intermediate opportunity to argue before DRP
• AO’s draft becomes final more easily

This choice determines your entire litigation strategy.

2. THE HISTORICAL CONTEXT: WHY DRP WAS CREATED FOR TP

The Problem DRP Was Designed to Solve

Pre-2009 Transfer Pricing Assessment:

• TPO made adjustments to transfer pricing
• AO simply accepted TPO’s adjustment or rejected it (minimal scrutiny)
• Cases went straight to appellate forum with no intermediate review
• Result: Inconsistent, chaotic transfer pricing outcomes

The 2009 Amendment (Finance Act 2009):

• Introduced the Dispute Resolution Panel (DRP) mechanism
• Mandated that TP adjustments must be reviewed by DRP before finalization
• DRP would be a specialized panel with transfer pricing expertise
• Rationale: Transfer pricing is highly technical; it needs intermediate expert review

The Legislative Intent

Section 144C was inserted with the expectation:

1. DRP would provide expert, technical review of transfer pricing
2. DRP could resolve disputes through reasoned analysis, not power play
3. Both Revenue and taxpayer would get a fair hearing before an expert panel
4. Litigation before ITAT would be reduced (through early settlement at DRP)
5. Transfer pricing outcomes would be consistent and predictable

3. SECTION 144C: THE STATUTORY FRAMEWORK (BARE PROVISIONS)

Section 144C(1) – Draft Order Requirement

“Where the Assessing Officer, having regard to the assessment record and such other material as he may consider necessary, determines that any income or loss is assessable to or allowable to the assessee and such determination involves any variation, express or implied, in the matter of transfer pricing, which is prejudicial to the assessee, the Assessing Officer shall make a draft assessment order…”

Translation:

• If AO proposes an upward transfer pricing adjustment (bad for the assessee), a draft must be issued first
• This is mandatory for TP cases (not optional)
• “Prejudicial” means any adjustment that increases tax liability

Section 144C(2) – Opportunity to Assessee

“The Assessing Officer shall, before finalizing the assessment order, serve on the assessee a copy of the draft assessment order, and the assessee may, within thirty days of the receipt of the draft order, submit in writing his objections to the draft order…”

Critical Timeline:

• 30 days to file objections with both AO and DRP
• Counted from receipt date of draft order
• No extension available (except in rare circumstances, judicially recognized)

What happens if you don’t file within 30 days:

• Objection rights are lost
• AO issues final order as per draft
• Only CIT(A) appeal available (not ITAT)

Section 144C(3) & (4) – DRP Referral

“The Assessing Officer may, after considering the objections submitted by the assessee, either accept or reject such objections. If the Assessing Officer is not satisfied with the objections, he shall refer the matter to the Dispute Resolution Panel…”

Key Provision: “Assessing Officer May”

This suggests AO has discretion. But jurisprudence clarifies: If objections are filed, AO MUST refer to DRP (not optional).

Section 144C(5) – DRP Directions Are Binding

“The Dispute Resolution Panel shall, after hearing the Assessing Officer and the assessee, issue directions in writing to the Assessing Officer specifying the manner in which the variation in the matter of transfer pricing should be worked out. The directions issued by the Dispute Resolution Panel shall be binding on the Assessing Officer, and the Assessing Officer shall, accordingly, finalize the assessment.”

This is the MOST IMPORTANT provision:

• DRP hears both sides (AO and assessee)
• DRP issues written directions
• These directions are BINDING on AO
• AO must follow them (no discretion to reject or modify)

Consequence: Once DRP issues directions, AO cannot change them. Final order must reflect DRP directions exactly.

Section 144C(6) – Assessee’s Rights Beyond DRP

“Notwithstanding anything to the contrary…the assessee shall have the right to appeal against the assessment order finalised under this section to the Income-tax Appellate Tribunal…”

Critical Point: Appeal is only to ITAT (not CIT(A))

This is a significant limitation on appellate forums compared to non-TP cases.

4. THE DRP PROCESS: A STEP-BY-STEP WALKTHROUGH

Stage 1: TPO Issues Transfer Pricing Adjustment (Pre-draft)

What happens:

• Transfer Pricing Officer (TPO, typically a specialized DGTP official) examines transfer pricing
• TPO identifies transfer pricing adjustment needed
• TPO reports the adjustment to the AO

Timeline: Typically completes within 6-9 months of AY end

Key Document: TPO Report (highly technical, containing transfer pricing analysis)

Stage 2: AO Issues Draft Order Under Section 144C(1)

What happens:

• AO incorporates TPO’s adjustment into a draft assessment order
• AO issues this draft order to the assessee with a letter explaining the adjustment
• Draft order specifies: Proposed transfer pricing adjustment amount, Arm’s Length Price (ALP) determined, Method used, etc.

Statutory Requirement: AO must specify the reasons for the adjustment

Copy Provided: Assessee gets:

• Draft order
• TPO report (or relevant extracts)
• AO’s letter explaining the variation

Timeline: AO issues draft typically 90-120 days after TPO report

Stage 3: The 30-Day Objection Window (CRITICAL)

Assessee’s Decision Point:

Assessee must decide within 30 days of receipt of draft order:

• Option A: File objections before DRP (invoke DRP route)
• Option B: Do nothing (waive DRP, go straight to CIT(A) later)

What Happens if Option A (File Objections):

Assessee submits:

• Written objections (detailed response to draft order)
• Supporting documents (transfer pricing study, comparable company analysis, etc.)
• Legal arguments (why ALP should be different)

Where to file:

• Original: To the Assessing Officer
• Copy: To the DRP (or DRP’s office; procedure varies by jurisdiction)

What happens if Option B (Do Nothing):

• Draft becomes final order
• Only CIT(A) appeal available
• Cannot later go to ITAT directly

Stage 4: AO Reviews Objections

What AO does:

• Examines assessee’s objections
• Considers whether objections raise valid points
• Records reasons for accepting or rejecting objections

Two possible outcomes:

1. AO accepts objections: Modifies draft order accordingly, issues final order (no DRP needed)
2. AO rejects objections or partially accepts: Refers matter to DRP under Section 144C(3)

Timeline: AO must complete within 60 days of receiving objections (approximately)

Stage 5: DRP Hearing (If Objections Filed & Not Fully Accepted)

DRP Composition:

• Typically 3 members (senior IRS officers with transfer pricing expertise)
• Independent from both TPO and AO
• Neutral forum

The Hearing:

• AO presents: Why the adjustment is justified (TPO’s case)
• Assessee presents: Why ALP should be different (assessee’s position)
• Questions: DRP members question both sides

Evidentiary Standard:

• More formal than CIT(A) proceedings but less formal than court proceedings
• DRP focuses on technical transfer pricing analysis
• Comparable company data, pricing models, industry benchmarks are central

Duration: Hearing typically 2-4 hours (sometimes multiple sessions)

Timeline: DRP hearing typically occurs 3-6 months after objections filed

Stage 6: DRP Issues Written Directions (Section 144C(5))

What DRP Does:

• Considers both AO and assessee submissions
• Makes an independent assessment of what the ALP should be
• Issues written directions specifying:
  • The correct ALP (in DRP’s view)
  • The methodology to be used
  • The adjustment amount to be incorporated

Form of Directions:

• Highly detailed, reasoned order
• Cites comparable companies, pricing methods, industry practice
• Addresses key contentious issues

Binding Nature:

• Directions are BINDING on AO
• AO cannot:
  • Reject DRP’s view
  • Modify DRP’s direction
  • Impose an alternative ALP
• AO must comply exactly

Timeline: DRP typically issues directions 30-60 days after hearing

Stage 7: AO Finalizes Assessment (Per DRP Directions)

What AO Does:

• Issues final assessment order incorporating DRP’s directions exactly
• Cannot deviate from DRP’s specified adjustment
• Issues to assessee with appeal notice

Final Order Specifics:

• Total income after transfer pricing adjustment (per DRP)
• Tax computed on this income
• Notice of Assessment (per Section 143(1) or 144)

Timeline: AO must finalize within 30 days of receiving DRP directions (approximately)

Stage 8: Assessee’s Appellate Rights

Sole Appellate Forum: Income Tax Appellate Tribunal (ITAT) (per Section 144C(6))

Why not CIT(A)? Because DRP already functioned as an intermediate appellate authority

What ITAT Can Do:

• Examine the entire case de novo (fresh examination)
• Review DRP’s reasoning
• Decide whether DRP’s ALP is justified
• Issue own directions to AO (if DRP was wrong)

ITAT’s Standard of Review:

• Not deferential to DRP (ITAT reviews on merits)
• But ITAT recognizes DRP’s expertise in transfer pricing

5. THE VODAFONE CASE: LANDMARK PRINCIPLES

Citation & Bench Details

Case: Vodafone Essar Ltd. vs. Dispute Resolution Panel & Others

Court: Delhi High Court

Citation: (2010) 325 ITR 43 (Delhi HC)

Date: December 10, 2010

Significance: First major High Court pronouncement on DRP’s role and powers under Section 144C

Facts of Vodafone

Company: Vodafone Essar (telecom company)

Issue: Transfer pricing adjustment for inter-company charges (management fees, support services)

TPO’s Addition: ₹200+ crores (claimed assessee undercharged service fees to related entities)

DRP’s Direction: Reduced TPO’s addition to ₹100+ crores (DRP found some charges reasonable)

AO’s Action: Initially tried to apply its own adjustment different from DRP’s

Dispute: Whether DRP’s directions are truly binding or whether AO can reinterpret them

High Court’s Key Holdings

Holding 1: DRP Directions Are Binding (Section 144C(5) Means Binding)

“The directions issued by the Dispute Resolution Panel are BINDING on the Assessing Officer. The AO has no discretion to reject, modify, or interpret DRP’s directions differently. The AO must implement DRP’s decision exactly as stated.”

Implication: DRP is the final authority in transfer pricing for AO. Not advisory; truly binding.

Holding 2: DRP Must Give Reasoned Directions

“The DRP must issue directions that are reasoned, supported by evidence, and not arbitrary. A direction that is unexplained or contrary to all evidence can be challenged before the ITAT, but once a DRP direction is reasonable and based on record, the AO must follow it.”

Implication: While DRP directions are binding on AO, they’re not immune from ITAT scrutiny. ITAT can examine if DRP’s reasoning was sound.

Holding 3: Distinction Between DRP Powers and Appellate Powers

“DRP is not merely another appellate authority. DRP is a specialized quasi-judicial body for transfer pricing. Its role is to make an independent determination of the ALP, not to review the AO’s order. This is why DRP directions are binding on AO—DRP is making a fresh determination.”

Implication: DRP ≠ CIT(A). DRP makes its own call on the ALP; CIT(A) reviews another’s decision.

Holding 4: Assessee Cannot Waive DRP Without Consequences

“If an assessee does not file objections before the DRP, the assessee loses the opportunity for intermediate expert review. While the assessee can still appeal to CIT(A), the opportunity to argue before DRP (a specialized forum) is forfeited. This is a strategic decision, not just a procedural technicality.”

Implication: Not filing DRP objections is a serious strategic error. It waives the benefit of DRP’s transfer pricing expertise.

The Broader Vodafone Principle

The Vodafone judgment essentially established:

DRP is the gate-keeper in transfer pricing assessment. Once DRP issues directions, the matter is essentially decided (barring ITAT reversal on judicial scrutiny grounds).

This gives DRP significant power in transfer pricing cases.

6. DRP OBJECTION FILING: PRACTICAL STRATEGIES

Pre-Filing Preparation

Step 1: Detailed Analysis of Draft Order

What to do:

• Obtain full draft order and TPO report
• Identify every transfer pricing issue raised
• Understand TPO’s methodology, comparable companies used, adjustments proposed
• Assess weaknesses in TPO’s analysis

Time needed: 5-7 days (minimum)

Step 2: Assemble Transfer Pricing Documentation

Gather:

• Your transfer pricing study (if one exists)
• Comparable company analysis
• Pricing models/benchmarking
• Functional analysis (showing functions, assets, risks)
• Board approvals for transfer pricing policies
• Contemporaneous documentation per Rule 10D

Why important: DRP expects to see contemporaneous TP documentation. Lack thereof weakens your case.

Step 3: Identify Key Contentious Issues

Focus on:

• Which comparable companies did TPO use? Are they truly comparable?
• Which pricing method did TPO use? Is it appropriate?
• Did TPO use correct financial metrics? (Turnover, cost, EBITDA?)
• What’s the range of ALP? Where does your position fall?

Why: DRP focuses on technical issues, not administrative complaints. Technical arguments win.

Filing the Objections

What to Include in Written Objections

1. Executive Summary (1-2 pages):

• Summary of objections
• Key issues identified
• Your proposed ALP
• Why your position is correct

2. Detailed Objections (20-30 pages):

• Point-by-point rebuttal of TPO’s findings
• Technical transfer pricing analysis
• Comparable company data
• Pricing method justification

3. Supporting Documents:

• Transfer pricing study
• Comparable company financials
• Emails/communications showing commercial rationale
• Industry reports

4. Legal Arguments (5-10 pages):

• Relevant transfer pricing regulations
• Case law (ITAT precedents, High Court judgments)
• Why TPO’s interpretation is erroneous

Total: 50-100 pages (typical for significant transfer pricing dispute)

Tone & Presentation

Do’s:

• Be professional and respectful
• Use technical language (shows competence)
• Cite precedents appropriately
• Acknowledge TPO’s points, then rebut them

Don’ts:

• Be aggressive or accusatory
• Use vague language (“TPO is wrong”)
• Make legal arguments without factual support
• Challenge TPO’s authority (attack the argument, not the person)

Filing Timelines & Procedures

30-Day Countdown:

• Day 1: Receive draft order
• Day 30: DEADLINE to file objections
• Filing location: AO’s office (and DRP’s office, per notice)

Extension Possibilities:

• No statutory extension available for Section 144C objections
• However, in rare cases (medical emergency, natural calamity), courts have extended timelines
• Better to file even incomplete objections on day 30 than miss deadline

Proof of Filing:

• Keep certified copy with receipt/acknowledgment
• Important for later disputes about timeliness

7. DRP DIRECTIONS & BINDING NATURE

What DRP Directions Look Like

Typical DRP Direction Structure:

DIRECTION ISSUED BY DISPUTE RESOLUTION PANEL

Under Section 144C(5) of the Income Tax Act, 1961

Case: ABC Ltd. vs. TPO

Transfer Pricing Issue: Inter-company Management Fees

─────────────────────────────────────────

1. BACKGROUND:

   [Summary of issue, TPO’s adjustment, assessee’s objections]

2. FINDINGS:

   – TPO determined ALP at ₹100 crores

   – Assessee claims ALP is ₹60 crores

   – DRP conducted independent analysis

3. COMPARABLE COMPANY ANALYSIS:

   [Details of comparable companies selected, financial metrics used]

4. PRICING METHODOLOGY:

   [Analysis of cost-plus method, market data, etc.]

5. DETERMINATION OF ALP:

   After considering all factors, DRP determines the ALP at ₹75 crores

6. ADJUSTMENT:

   Transfer pricing adjustment to be made: ₹75 crores

   (Not TPO’s ₹100 crores; not assessee’s ₹60 crores)

7. BINDING DIRECTION:

   The AO SHALL incorporate the transfer pricing adjustment of ₹75 crores

   in the final assessment order.

   SIGNED: DRP Panel

The Binding Effect in Practice

Once DRP Issues Direction:

AO MUST:

• Incorporate exactly ₹75 crores adjustment
• Cannot change to ₹100 crores (TPO’s proposal)
• Cannot negotiate for ₹80 crores
• Cannot apply a different methodology

AO CANNOT:

• Reject the direction
• Say “I disagree with DRP”
• Impose conditions (“I’ll apply DRP’s direction only if…”)
• Seek reconsideration from DRP

Legal Consequence: If AO violates DRP direction, the final order is void and subject to writ petition.

What Happens If DRP Directions Appear Unreasonable?

In rare cases, DRP’s direction may appear illogical or against the record.

Remedies:

1. Before ITAT: Assessee can argue DRP’s direction is unreasonable and should be set aside.
2. Before High Court (Writ): In extreme cases (DRP acted arbitrarily), writ petition possible.
3. Jurisdictional Challenge: If DRP exceeded its powers, writ available.

But: Courts are reluctant to overturn DRP directions (respecting DRP’s specialized expertise). High threshold.

8. APPELLATE RIGHTS AFTER DRP

Key Point: Appeal to ITAT Only, Not CIT(A)

Section 144C(6) makes clear:

“The assessee shall have the right to appeal against the assessment order finalised under this section to the Income-tax Appellate Tribunal…”

This means:

• No CIT(A) appeal possible for TP cases where DRP was involved
• Direct appeal to ITAT
• Skips the CIT(A) layer entirely

Consequence:

• Some say assessee is benefited (ITAT is higher, more experienced tribunal)
• Others say assessee is disadvantaged (no intermediate review at CIT(A), which is more accessible)

What Can ITAT Examine?

After DRP issues directions, ITAT can:

1. Re-examine the transfer pricing on merits:
   • Was DRP’s ALP correct?
   • Should ALP be different?
   • Were DRP’s comparable companies truly comparable?
2. Review DRP’s reasoning:
   • Was DRP’s analysis sound?
   • Did DRP properly apply transfer pricing regulations?
   • Did DRP consider all material documents?
3. Examine AO’s compliance with DRP direction:
   • Did AO implement DRP’s direction exactly?
   • Did AO add any unauthorized adjustments?

What ITAT CANNOT do:

• Ignore DRP’s determination completely
• Give deference to DRP (ITAT reviews independently, but DRP’s analysis carries weight as expert opinion)

ITAT’s Standard of Review

ITAT applies (implicitly) a principle of:

“DRP’s determination is not binding on ITAT, but DRP’s reasoning (as a specialized body) deserves careful consideration. If ITAT disagrees with DRP, ITAT should give clear reasons.”

In practice:

• ITAT sometimes affirms DRP’s direction
• Sometimes ITAT modifies (sets ALP at different level)
• Rarely does ITAT completely reverse without clear reasoning

Statistics on ITAT Outcomes

Historical data (approximate):

• 60% of cases: ITAT affirms DRP’s direction (or makes minor modifications)
• 30% of cases: ITAT modifies DRP’s direction significantly
• 10% of cases: ITAT substantially reverses DRP

This shows: DRP’s directions are generally upheld, but ITAT retains meaningful review power.

9. KEY PITFALLS & STRATEGIC CONSIDERATIONS

Pitfall 1: Missing the 30-Day Deadline

Consequence:

• Objection rights forfeited
• AO’s draft becomes final
• Only CIT(A) appeal (not ITAT)
• Weakened position

Prevention:

• Mark calendar immediately upon receiving draft
• Set internal deadline 5 days before statutory deadline (buffer for processing)
• File even if incomplete (can supplement later, typically)

Pitfall 2: Weak Comparable Company Analysis

Consequence:

• DRP discards your analysis
• DRP adopts TPO’s comparables
• You lose key argument

Prevention:

• Commission professional transfer pricing study BEFORE DRP hearing
• Use latest databases (Bloomberg, Prowess, etc.)
• Ensure comparables are truly in the same industry, geography, business model

Pitfall 3: Failing to Address TPO’s Key Finding

Consequence:

• DRP considers your objections incomplete
• DRP infers you have no answer to TPO’s point
• DRP may side with TPO on that point

Prevention:

• Point-by-point address each of TPO’s findings
• If you cannot rebut a point, acknowledge it and explain why it doesn’t change the ultimate ALP

Pitfall 4: Presenting Only Legal Arguments, Not Technical Ones

Consequence:

• DRP (a technical body) wants transfer pricing analysis, not law
• Generic legal arguments don’t persuade on transfer pricing

Prevention:

• Lead with transfer pricing analysis (comparable companies, pricing methods)
• Use law to support technical findings, not vice versa

Pitfall 5: Not Preparing for DRP Hearing

Consequence:

• Unprepared answers at hearing
• DRP loses confidence in your position
• DRP sides with AO

Prevention:

• Mock hearing (internal rehearsal)
• Prepare senior team member who understands transfer pricing deeply
• Anticipate tough questions from DRP; prepare answers

10. CONCLUSION: DRP AS BOTTLENECK & GATEWAY

DRP’s Dual Role

As Bottleneck:

• DRP adds delay (3-6 months additional)
• DRP limits your appellate options (no CIT(A) after DRP)
• DRP’s binding directions limit negotiation flexibility

As Gateway:

• DRP offers expert technical review (transfer pricing specialists)
• DRP can reduce overly aggressive TPO adjustments
• DRP’s direction ends uncertainty (binding, final for AO purposes)

Strategic Decision: To Invoke DRP or Not?

Consider invoking DRP if:

• TPO’s adjustment is clearly excessive
• You have strong comparable company analysis
• You can present sophisticated transfer pricing arguments
• You want intermediate expert review before ITAT

Consider NOT invoking DRP if:

•  Your transfer pricing position is weak
• You lack contemporary TP documentation
• You prefer traditional CIT(A) appeal (more familiar forum)
• You want speed (DRP adds time)

The Vodafone Lesson Revisited

The Vodafone case teaches:

1. DRP is powerful: Its directions bind AO
2. DRP is specialized: It makes independent transfer pricing determinations
3. DRP matters: Invoking it is a strategic choice with lasting consequences
4. ITAT remains available: For those dissatisfied with DRP, ITAT review is available

References

[1] Bombay HC lays down Transfer Pricing law; explains Sec. 92CA scope, DRP powers Available at: Vodafone detailed Summary.pdf

[2] Dispute Resolution Mechanism Under Transfer Pricing Available at: DRP Income Tax | Dispute Resolution Panel | Section 144C | Sorting Tax

[3] DRAFT ASSESSMENT ORDER UNDER SECTION 144C OF INCOME TAX ACT, 1961 – MANDATORY? Available at: DRAFT ASSESSMENT ORDER UNDER SECTION 144C OF INCOME TAX ACT, 1961 – MANDATORY?

[4] AO Can’t Delay Assessment Citing Belated DRP Objections u/s 144C Available at: AO Can’t Delay Assessment Citing Belated DRP Objections u/s 144C | HC

[5] Vodafone Essar Ltd vs. Dispute Resolution Panel (Delhi High Court) Available at: Vodafone Essar Ltd vs. Dispute Resolution Panel (Delhi High Court) – itatonline.org

[6 Additions affirmed by DRP without considering objection of Assessee order was set-aside Available at: https://taxguru.in/income-tax/additions-affirmed-drp-objection-assessee-order-setaside.html

The post DRP in Transfer Pricing Assessment: Appellate Rights and Lessons from Vodafone appeared first on Bhatt & Joshi Associates.